ファンサも貰えて、桜キーホルダー🌸も自引き出来て、最高の広島でした🍁
このキーホルダー可愛すぎる💙

#MILK
#BIGLOVEYEAR

It was wonderful to catch up w/ Karthik Ramasamy (OUH) at #BSH2024 and hear about the use of MRD to guide treatment decisions and accelerate drug approvals in #MultipleMyeloma —a hot topic in the field, as we all know! 🙌

🎥 ow.ly/AnoP50RtFYY

#mmMRD #MMSM #HemOnc

. SWOG Cancer Research Network S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease ( #mmMRD ) to direct Therapy Duration (DRAMMATIC) - Dr. Amrita Krishnan Hoering, Phari Sexton, Robert Z. Orlowski #ASH20 Abst 1515 ow.ly/U9xg50FYWgt #NCT04071457 #mmsm

. SWOG Cancer Research Network S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease ( #mmMRD ) to direct Therapy Duration (DRAMMATIC) - Dr. Amrita Krishnan Hoering, Phari Sexton, Robert Z. Orlowski #ASH20 Abst 1515 ow.ly/U9xg50FYWgt #NCT04071457 #mmsm

. SWOG Cancer Research Network S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease ( #mmMRD ) to direct Therapy Duration (DRAMMATIC) - Dr. Amrita Krishnan Hoering, Phari Sexton, Robert Z. Orlowski #ASH20 Abst 1515 ow.ly/U9xg50FYWgt #NCT04071457 #mmsm

. SWOG Cancer Research Network S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease ( #mmMRD ) to direct Therapy Duration (DRAMMATIC) - Dr. Amrita Krishnan Hoering, Phari Sexton, Robert Z. Orlowski #ASH20 Abst 1515 ow.ly/U9xg50FYWgt #NCT04071457 #mmsm

Clinician attitudes and practices toward measurable residual disease in multiple myeloma [Jun 7, 2020] Ben Derman Jagoda Andrzej Jakubowiak Brit J Haematol ow.ly/3GSO50Cr8Mc #mmsm #mmMRD

#EAOnc EQUATE EAA181 Effective Quadruplet Utilization After Tx Evaluation: Ph3 RCT NDMM Not Intended for Early ASCT [Activated: 10/27/20] PI= Shaji Kumar ow.ly/aVr250BZ0dw #NCT04566328 #mmMRD #mmsm ECOG-ACRIN Cancer Research Group @mweissmdphd Vincent Rajkumar Lynne I Wagner PhD Wei Snyder Kostakoglu Mike Thompson, MD, PhD, FASCO

#EAOnc EQUATE EAA181 Effective Quadruplet Utilization After Tx Evaluation: Ph3 RCT NDMM Not Intended for Early ASCT [Activated: 10/27/20] PI= Shaji Kumar ow.ly/aVr250BZ0dw #NCT04566328 #mmMRD #mmsm ECOG-ACRIN Cancer Research Group @mweissmdphd Vincent Rajkumar Lynne I Wagner PhD Wei Snyder Kostakoglu Mike Thompson, MD, PhD, FASCO

Clinician attitudes and practices toward measurable residual disease in multiple myeloma [Jun 7, 2020] Ben Derman Jagoda Andrzej Jakubowiak Brit J Haematol ow.ly/3GSO50Cr8Mc #mmsm #mmMRD

Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma [Jul 11, 2022] Ben Derman Andrzej Jakubowiak Mike Thompson, MD, PhD, FASCO Blood Cancer Journal nature.com/articles/s4140… #mmMRD #mmsm #openaccess

#EAOnc EQUATE EAA181 Effective Quadruplet Utilization After Tx Evaluation: Ph3 RCT NDMM Not Intended for Early ASCT [Activated: 10/27/20] PI= Shaji Kumar ow.ly/aVr250BZ0dw #NCT04566328 #mmMRD #mmsm ECOG-ACRIN Cancer Research Group @mweissmdphd Vincent Rajkumar Lynne I Wagner PhD Wei Snyder Kostakoglu Mike Thompson, MD, PhD, FASCO

女性セブンの太智のページが全部見事にブルーで可愛かった💙

Clinician attitudes and practices toward measurable residual disease in multiple myeloma [Jun 7, 2020] Ben Derman Jagoda Andrzej Jakubowiak Brit J Haematol ow.ly/3GSO50Cr8Mc #mmsm #mmMRD

雨予報⋆̩☂︎*̣̩だけど、心は晴れ☀️でハッピーにいきましょう！！！！！

Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma [Jul 11, 2022] Ben Derman Andrzej Jakubowiak Mike Thompson, MD, PhD, FASCO Blood Cancer Journal nature.com/articles/s4140… #mmMRD #mmsm #openaccess

太智おつかれさまー！！！！！
私も一緒に飛んだよー(笑)
#スポ男

🧂まるちゃん🧂 ね〜💙めちゃくちゃ楽しそうで何よりだ！笑

🧂まるちゃん🧂 だよねー！個人的にはヒルナンデスのディズニー特集に出てもらいたいわ🫶

#mmMRD healthcare social media hashtag [Nov 21, 2020] Minimal/measurable residual disease (MRD) in multiple myeloma. Submitted by Ben Derman to Symplur Healthcare Hashtag Project symplur.com/healthcare-has… #mmsm